Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal vaccine

Neisseria meningitidis vaccine · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Meningococcal vaccine, covering 2013-12-30 to 2017-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years [Phase 3]

See pricing